Top stories
01
OpenAI: Fundraising race intensifies
OpenAI is reportedly accelerating plans for a potential $30 billion fundraising round, which could value the company at more than $1.4 trillion. The reported timetable reflects intensifying competition for investor capital as leading AI companies pursue ambitious growth plans.
Source: Reuters
02
Anthropic: Preparing for a potential listing
Anthropic has announced plans to dedicate 5% of its shares to a new Public Benefit Fund, subject to the relevant approvals. The announcement comes amid reporting about a potential IPO, although the timing and final terms remain uncertain.
Source: Anthropic
03
Revolut: Future listing options remain in focus
Revolut's founder has discussed the possibility of a dual listing in London and New York. The company has not confirmed a definitive listing timetable, and any future IPO remains subject to its plans and market conditions.
Source: Reuters
04
European AI: Legora raises $550 million
Swedish legal AI company Legora announced a $550 million Series E funding round at an $8.8 billion valuation. The company plans to use the capital to expand internationally and develop its AI capabilities.
Source: Reuters
The bigger picture
Valuation versus fundamentals: large private-company valuations warrant scrutiny of revenue, growth, capital requirements, competitive position and the path to profitability. IPO timing and execution: a reported IPO plan is not a confirmed listing. Liquidity before listing: secondary transactions may offer eligible shareholders a route to sell before an IPO where a willing buyer and approvals are available, but liquidity is not guaranteed.
What readers should watch
Revenue quality, operating margins, capital requirements, valuation methodology and the terms of any future liquidity event. A private-market valuation is not a guaranteed exit price, and a possible IPO does not guarantee a listing, allocation or investment return.
Important information: This newsletter is for general information and research purposes only. It is not an offer, solicitation or personal investment advice. Private-company valuations may be indicative, transaction-specific and illiquid.
